226
Participants
Start Date
July 17, 2020
Primary Completion Date
July 28, 2021
Study Completion Date
September 22, 2021
CBP-201
CBP-201 subcutaneous(SC) injection.
placebo
subcutaneous(SC) injection
Connect Investigative Site 203, Auckland
Connect Investigative Site 104, Darlinghurst
Connect Investigative Site 108, Kanwal
Connect Investigative Site 105, Sydney
Connect Investigative Site 111, Canberra
Connect Investigative Site 102, Melbourne
Connect Investigative Site 204, Tauranga
Connect Investigative Site 101, Brisbane
Connect Investigative Site 202, Havelock North
Connect Investigative Site 205, Waikanae
Connect Investigative Site 103, Perth
Connect Investigative Site 106, Fremantle
Connect Investigative Site 319, Hunt Valley
Connect Investigative Site 308, Jacksonville
Connect Investigative Site 314, Maitland
Connect Investigative Site 304, Orlando
Connect Investigative Site 320, Hialeah
Connect Investigative Site 306, Hollywood
Connect Investigative Site 332, Coral Gables
Connect Investigative Site 331, Miami
Connect Investigative Site 337, Miami
Connect Investigative Site 321, Miami
Connect Investigative Site 340, Weston
Connect Investigative Site 309, Memphis
Connect Investigative Site 311, Louisville
Connect Investigative Site 330, Cincinnati
Connect Investigative Site 307, New Albany
Connect Investigative Site 313, West Lafayette
Connect Investigative Site 328, Rapid City
Connect Investigative Site 333, Chicago
Connect Investigative Site 303, Chicago
Connect Investigative Site 315, St Louis
Connect Investigative Site 335, Saint Joseph
Connect Investigative Site 305, Little Rock
Connect Investigative Site 334, Houston
Connect Investigative Site 338, Phoenix
Connect Investigative Site 316, Tempe
Connect Investigative Site 310, Glendale
Connect Investigative Site 326, Albuquerque
Connect Investigative Site 336, Las Vegas
Connect Investigative Site 327, Canoga Park
Connect Investigative Site 325, Thousand Oaks
Connect Investigative Site 318, Sherman Oaks
Connect Investigative Site 324, Encinitas
Connect Investigative Site 322, San Diego
Connect Investigative Site 312, Huntington Beach
Connect Investigative Site 329, Mission Viejo
Connect Investigative Site 317, Santa Ana
Connect Investigative Site 323, San Luis Obispo
Connect Investigative Site 301, Fremont
Connect Investigative Site 408, Beijing
Connect Investigative Site 404, Beijing
Connect Investigative Site 401, Shanghai
Connect Investigative Site 406, Shanghai
Connect Investigative Site 409, Zhenjiang
Connect Investigative Site 405, Wuxi
Connect Investigative Site 402, Jinan
Connect Investigative Site 410, Tianjin
Connect Investigative Site 403, Hangzhou
Lead Sponsor
Connect Biopharm LLC
INDUSTRY